Vical Incorporated · San Diego, CA United States ·(NASDAQ (GM): VICL)
Company Description
View Vical Incorporated Locations On A US Map
This link will open in a new window
This link will open in a new window Vical counts DNA as its main ally in the war against infectious disease. The biopharmaceutical firm develops vaccines for the prevention and treatment of viruses and various forms of cancer based on its DNA delivery technology, which uses portions of the genetic code of a pathogen to induce an immune response. Vical has partnered with Merck , Sanofi-Aventis , and National Institutes of Health to fight Hepatitis C, HIV, ebola, and peripheral arterial disease. On its own, it has clinical trials under way for vaccines against Herpes strain cytomegalovirus, flu, and SARS. Its lead product candidate is Allovectin-7, an immunotherapy for melanoma (skin cancer); latter-stage clinical trials are being funded by AnGes MG. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Vical Incorporated Financials
| Company Type | Public - NASDAQ (GM): VICL Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $8.0 |
| 2008 Employees | 118 |
Vical Incorporated Executives
12 executives listed for Vical Incorporated's San Diego, CA location.
| Title | Name & Bio | Contact |
| Chairman | R. Gordon Douglas | Network |
| President, CEO, and Director | Vijay Samant | Network |
| SVP Business Operations | Robin Jackman | Network |
Competition
Competitive Landscape for Vical Incorporated
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Vical Incorporated Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!